Log in
Enquire now
‌

US Patent 7514444 Inhibitors of bruton's tyrosine kinase

Patent 7514444 was granted and assigned to Pharmacyclics on April, 2009 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Current Assignee
Pharmacyclics
Pharmacyclics
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7514444
Patent Inventor Names
Lee Honigberg0
Zhengying Pan0
Erik Verner0
Date of Patent
April 7, 2009
Patent Application Number
11617645
Date Filed
December 28, 2006
Patent Citations Received
‌
US Patent 12131473 Systems and methods for processing images to prepare slides for processed images for digital pathology
0
‌
US Patent 11970500 Crystalline form of (s)-7-(1-acryloylpiperidin-4-yl)- 2-(4-phenoxyphenyl)-4,5,6,7-tetra- hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof
0
‌
US Patent 11999743 Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof
0
‌
US Patent 12006329 Protein degraders and uses thereof
0
‌
US Patent 12077555 STAT degraders and uses thereof
0
‌
US Patent 12091411 IRAK degraders and uses thereof
0
‌
US Patent 12103931 Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof
0
‌
US Patent 11701357 Treatment of B cell cancers using a combination comprising Btk inhibitors
0
...
Patent Primary Examiner
‌
James O. Wilson
Patent abstract

Disclosed herein are compounds that form covalent bonds with Bruton's tyrosine kinase (Btk). Also described are irreversible inhibitors of Btk. Methods for the preparation of the compounds are disclosed. Also disclosed are pharmaceutical compositions that include the compounds. Methods of using the Btk inhibitors are disclosed, alone or in combination with other therapeutic agents, for the treatment of autoimmune diseases or conditions, heteroimmune diseases or conditions, cancer, including lymphoma, and inflammatory diseases or conditions.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7514444 Inhibitors of bruton's tyrosine kinase

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.